Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Accounts Payables (2020 - 2025)

Cellebrite DI's Accounts Payables history spans 6 years, with the latest figure at $16.8 million for Q4 2025.

  • Quarterly Accounts Payables fell 73.42% to $16.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $16.8 million through Dec 2025, down 73.42% year-over-year, with the annual reading at $16.8 million for FY2025, 73.42% down from the prior year.
  • Accounts Payables came in at $16.8 million for Q4 2025, up from $11.1 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $63.3 million in Q4 2024 to a low of $3.8 million in Q2 2022.
  • The 5-year median for Accounts Payables is $8.6 million (2022), against an average of $15.2 million.
  • Year-over-year, Accounts Payables skyrocketed 376.15% in 2022 and then crashed 73.42% in 2025.
  • Cellebrite DI's Accounts Payables stood at $9.5 million in 2021, then surged by 376.15% to $45.5 million in 2022, then fell by 1.34% to $44.8 million in 2023, then soared by 41.22% to $63.3 million in 2024, then plummeted by 73.42% to $16.8 million in 2025.
  • Per Business Quant, the three most recent readings for CLBT's Accounts Payables are $16.8 million (Q4 2025), $11.1 million (Q3 2025), and $10.6 million (Q2 2025).